Lab Consumables Market Size, Growth Trends & Insights Analysis Report by Type (Pipettes, Tubes, Tips, Cuvettes, Dishes, Gloves, Masks, Cell Culture Consumables, Flasks, Others), by Application (Academia, Pharmaceutical, CRO, Diagnostics, Others), by Region, and Competitive Landscape Forecasts, 2024-2033

The global Lab Consumables market is valued at USD 22223 million in 2024. The CAGR is expected to be approximately 8.8% from 2024 to 2033.

Lab Consumables are equipment that only have limited use, as in it can be used until it is ‘run out’ and then must be disposed of. The types of consumables include but not limited to pipettes, tubes, tips, cuvettes, dishes, gloves, masks, cell culture consumables, flasks and more.

Lab Consumables Market

The driving factors for the growth of the global lab consumables market mainly include the increase in downstream market demand, the trend of population aging, and the continuous development of the biopharmaceutical industry. With the advancement of science and technology, the status of medical testing in disease prevention and treatment has become increasingly important. The development of cutting-edge medicine such as precision medicine and targeted therapy is inseparable from medical testing, which has led to a continuous increase in the demand for lab consumables. For example, in developed countries, the annual per capita use of vacuum blood collection tubes alone is about 6 tubes/person.

At the same time, the global aging population is aggravated, the prevalence of chronic diseases among the elderly is increasing, and the medical demand is expanding, which further promotes the development of the lab consumables market. The research and development activities in the biopharmaceutical industry are becoming increasingly active, and the prevalence of various genetic diseases and chronic diseases has prompted biotechnology companies to increase their investment in research and development and develop new drugs and diagnostic technologies, thereby driving the market demand for lab consumables. However, the development of this market also faces some limiting factors.

On the one hand, there are many companies in the industry and the competition is fierce. If manufacturers cannot surpass their competitors in terms of product quality, sales channels and R&D strength, it will be difficult to maintain their market position, which may lead to the loss of market share and a decline in corporate operating performance. For example, in some common consumables with low technical content, many small companies are in fierce competition, products are highly homogenized, and profit margins are compressed.

On the other hand, raw material price fluctuations have a greater impact on the industry. Raw materials are an important component of lab consumables production, accounting for a large part of production costs, and their price fluctuations directly affect product quality and corporate profits. In recent years, global commodity price fluctuations have intensified, and most lab consumables manufacturers are facing pressure from rising raw material costs. If they cannot effectively reduce costs, improve efficiency, and maintain product price competitiveness, gross profit margins and operating performance will be affected.

The global lab consumables market has shown a positive development trend in terms of technological innovation and corporate mergers and acquisitions. In terms of technological innovation, it is mainly reflected in the iteration of materials, product equipment and processing technology. In terms of materials, with the expansion of biotechnology application scenarios, the requirements for material performance of products have increased, and raw materials have gradually changed from ordinary polymer materials to higher biosafety standards such as medical-grade polymer materials and degradable materials to meet the use needs of products in the biomedical and medical health fields.

In terms of product equipment iteration, although there is still demand for traditional consumables such as plates, bottles, and dishes for ordinary cell culture, the expansion of cell culture applications in the biomedical field has promoted the material modification and equipment upgrade of cell culture tools to meet higher cell culture technology requirements.

In terms of processing technology, the production and processing technologies of disposable plastic consumables in biological laboratories, such as injection molding and extrusion, have developed steadily, and in the future they will develop in the direction of improving automation levels and equipment precision to improve product quality and production efficiency.

In terms of corporate mergers and acquisitions, the biopharmaceutical industry has frequent mergers and acquisitions, which has also indirectly affected the lab consumables market. For example, in 2020, Gilead Sciences acquired Immunomedicine for $2.1 billion, and Illumina plans to acquire cancer blood test developer Grail for $800 million. These mergers and acquisitions have promoted the development of the biopharmaceutical industry, which in turn increased the demand for lab consumables. For lab consumables companies, mergers and acquisitions can achieve resource integration, technology sharing, and market expansion.

For example, some large companies quickly improve their R&D capabilities and product competitiveness and further consolidate their market position by acquiring small companies with advanced technologies or unique products. At the same time, corporate mergers and acquisitions can also help optimize the industry structure, increase industry concentration, drive resources to concentrate on advantageous companies, and promote the healthy development of the entire industry.

Pipettes are essential tools used for measuring and transferring small volumes of liquid in laboratory settings. In 2024, the pipette segment is projected to generate a market value of $1188.2 million (M USD), accounting for approximately 5.35% of the total market share. This segment includes various types of pipettes, such as manual and electronic pipettes, designed for precision and accuracy in laboratory applications.

Tubes are widely used for storing and transporting samples in laboratories. The tubes segment is expected to reach a market value of $3039.0 million (M USD) in 2024, representing 13.67% of the total market share. These tubes come in various materials (such as glass and plastic) and sizes, catering to different laboratory requirements, from simple sample storage to complex analytical processes.

Tips, particularly pipette tips, are crucial for ensuring contamination-free sample handling. In 2024, the tips segment is forecasted to achieve a market value of $2330.3 million (M USD), holding a market share of 10.49%. These tips are available in various sizes and materials, designed to fit different pipetting systems and meet specific laboratory needs.

Cuvettes are small containers used to hold samples for spectroscopic analysis. The cuvettes segment is projected to have a market value of $240.1 million (M USD) in 2024, contributing 1.08% to the total market share. These cuvettes are typically made from materials like glass or plastic, with high optical clarity to ensure accurate measurements.

Dishes, such as Petri dishes, are fundamental for culturing cells and microorganisms. In 2024, the dishes segment is expected to generate a market value of $1223.4 million (M USD), accounting for 5.51% of the total market share. These dishes are essential for microbiology and cell culture applications, with features like sterile environments and proper ventilation.

Gloves are vital for protecting laboratory personnel from hazardous materials and contaminants. The gloves segment is projected to reach a market value of $1030.1 million (M USD) in 2024, holding a market share of 4.64%. These gloves come in various materials, including latex, nitrile, and vinyl, offering different levels of protection and durability.

Masks are essential for protecting against airborne contaminants and ensuring laboratory safety. In 2024, the masks segment is expected to generate a market value of $709.5 million (M USD), contributing 3.19% to the total market share. These masks are designed to filter out particulates and provide protection during laboratory procedures.

Cell culture consumables are a broad category that includes flasks, dishes, and other tools used for culturing cells. In 2024, this segment is projected to achieve a market value of $6389.4 million (M USD), accounting for 28.75% of the total market share. These consumables are essential for cell biology research and biotechnology applications, with a focus on maintaining sterile and optimal growth conditions.

Flasks are used for various laboratory applications, including mixing, heating, and storing solutions. In 2024, the flasks segment is expected to generate a market value of $1506.6 million (M USD), contributing 6.78% to the total market share. These flasks come in different shapes and sizes, designed to meet specific laboratory needs.

Type

Market Size (M USD) 2024

Market Share 2024

Pipettes

1188.2

5.35%

Tubes

3039.0

13.67%

Tips

2330.3

10.49%

Cuvettes

240.1

1.08%

Dishes

1223.4

5.51%

Gloves

1030.1

4.64%

Masks

709.5

3.19%

Cell Culture Consumables

6389.4

28.75%

Flasks

1506.6

6.78%

Others

4566.4

20.55%

Academia remains a significant application area. In 2024, the market revenue for lab consumables in academia is expected to reach 4,268.7 M USD. This accounts for approximately 19.21% of the total global lab consumables market value. Academic institutions, including research and teaching labs, rely heavily on lab consumables for a wide range of experiments and studies.

Research labs in academia often conduct cutting – edge research in biology, chemistry, and medicine, which requires a continuous supply of high – quality pipettes, tubes, and cell culture consumables. Teaching labs, on the other hand, need these consumables for student training and educational experiments.

The pharmaceutical sector is another major application. In 2024, its market revenue is projected to be 5,551.4 M USD, with a market share of around 24.98%. Pharmaceutical laboratories are engaged in activities such as method development, clinical trials, raw materials testing, and bioanalytical testing. They require a large quantity of specialized lab consumables. For example, in drug development, accurate pipettes and high – quality cuvettes are essential for conducting assays and analyzing samples.

Contract Research Organizations (CROs) also play a crucial role in the lab consumables market. In 2024, the market revenue for CROs is estimated at 3,322.5 M USD, making up about 14.95% of the total market. CROs are contracted by other companies to manage complex medical testing and trials. Their operations involve a high volume of sample handling, which drives the demand for tubes, tips, and other consumables.

Diagnostics is an application segment that has been growing steadily. In 2024, the market revenue for diagnostics is expected to be 4,010.9 M USD, with a market share of approximately 18.05%. Diagnostic labs work closely with medical practices to provide essential information for disease diagnoses. They use a variety of lab consumables, such as collection tubes for blood and other samples, and specialized plates for testing. The increasing demand for accurate and rapid diagnostic tests, especially in the context of global health concerns, has been fueling the growth of this segment.

Application

Market Size (M USD) 2024

Market Share 2024

Academia

4268.7

19.21%

Pharmaceutical

5551.4

24.98%

CRO

3322.5

14.95%

Diagnostics

4010.9

18.05%

Others

5069.5

22.81%

North America is a dominant region in the global lab consumables market. In 2024, its market revenue is projected to be 8,118.9 M USD, representing approximately 36.53% of the total global market value. The region benefits from its highly developed economy, advanced medical and research infrastructure, and strong investment in scientific research.

The United States, in particular, has a large number of pharmaceutical companies, research institutions, and diagnostic centers. These entities drive the demand for high – quality lab consumables. For example, in biopharmaceutical R & D, North American companies are at the forefront of developing new drugs, which requires a vast amount of sophisticated lab consumables.

The EU is another major region in the market. In 2024, the EU’s lab consumables market revenue is expected to be 6,796.5 M USD, with a market share of around 30.58%. Europe has a long – standing tradition of excellence in scientific research and a well – developed pharmaceutical industry. Many European countries have invested heavily in biotechnology and medical research. The EU also has strict regulations regarding product quality and safety, which encourages the use of high – standard lab consumables. For instance, in academic research and clinical trials across Europe, the demand for reliable and precise lab consumables is consistently high.

The Asia – Pacific region has been emerging as a significant player in the global lab consumables market. In 2024, its market revenue is estimated at 5,557.2 M USD, accounting for about 25.01% of the total market. The region’s growth can be attributed to several factors. Firstly, countries like China and India have a large population, which means a vast potential market for medical and research applications. Secondly, there has been a growing investment in the biotechnology and pharmaceutical industries in the Asia – Pacific.

For example, China has been increasing its R & D spending in areas such as gene therapy and personalized medicine, which has led to a higher demand for lab consumables. Additionally, the improving healthcare infrastructure in the region is also driving the growth of the lab consumables market.

South America has a relatively smaller but growing market for lab consumables. In 2024, the market revenue in South America is expected to be 995.6 M USD, with a market share of about 4.48%. Although the region is composed mainly of developing countries, there has been an increasing focus on improving healthcare and scientific research. Countries like Brazil and Argentina are investing more in medical research and diagnostics, which is boosting the demand for lab consumables. However, the market in South America still faces challenges such as economic instability in some countries, which can affect the growth rate.

The Middle East and Africa region also contribute to the global lab consumables market. In 2024, the market revenue in this region is projected to be 754.8 M USD, with a market share of around 3.40%. The Middle East has been investing in improving its healthcare and research capabilities, especially in countries with significant oil revenues. Africa, on the other hand, is gradually developing its healthcare infrastructure. However, the region also faces challenges such as a lack of advanced medical facilities in some areas and limited access to high – quality lab consumables. Despite these challenges, the increasing awareness of the importance of accurate medical testing and research in the region is driving the growth of the lab consumables market.

Lab Consumables Market

Company Introduction and Business Overview:

Thermo Fisher Scientific Inc., established in 1956 and headquartered in the USA, is a global leader in serving science. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher Scientific develops, manufactures, and sells a wide range of products and services, catering to various scientific and laboratory needs. Its product portfolio includes high-quality lab consumables such as pipette tips, cell culture media, and other essential lab tools. The company’s extensive offerings and strong focus on innovation have solidified its position as a market leader.

Products:

Thermo Fisher Scientific offers a comprehensive range of lab consumables, including pipette tips, cell culture media, and other essential lab tools. These products are designed to meet the highest standards of quality and reliability, supporting researchers and scientists in their work.

Market Performance in 2022:

In 2022, Thermo Fisher Scientific reported a revenue of $2,428.2 million and a gross profit of $1,257.0 million, with a gross margin of 51.77%.

Company Introduction and Business Overview:

MilliporeSigma, established in 1954 and headquartered in the USA (with its parent company Merck KGaA in Germany), is a leading manufacturer of chemicals and bio-chemicals. The company provides a wide range of organic chemical products, kits, and services used in scientific research, biotechnology, pharmaceutical development, and diagnostics.

MilliporeSigma operates under the Life Science business sector of Merck KGaA. It offers a comprehensive portfolio of products and services, including lab consumables such as cell culture supplies, pipettes, and other essential tools. The company’s focus on innovation and quality has enabled it to maintain a strong market presence.

Products:

MilliporeSigma’s product offerings include a wide range of lab consumables, such as cell culture supplies, pipettes, and other essential tools. These products are designed to meet the highest standards of quality and reliability, supporting researchers and scientists in their work.

Market Performance in 2022:

In 2022, MilliporeSigma reported a revenue of $1,202.8 million and a gross profit of $531.0 million, with a gross margin of 44.15%.

Company Introduction and Business Overview:

Danaher Corporation, established in 1969 and headquartered in the USA, is a global science and technology innovator. The company operates through more than 20 independent operating companies, focusing on healthcare, environmental, and applied end-markets.

Danaher Corporation is known for its diverse portfolio of products and services, including lab consumables such as tubes, pipettes, and other essential tools. The company’s strong focus on innovation and quality has enabled it to maintain a leading position in the market.

Products:

Danaher Corporation offers a wide range of lab consumables, including tubes, pipettes, and other essential tools. These products are designed to meet the highest standards of quality and reliability, supporting researchers and scientists in their work.

Market Performance in 2022:

In 2022, Danaher Corporation reported a revenue of $1,553.2 million and a gross profit of $735.3 million, with a gross margin of 47.34%.

Share your love
en_USEnglish